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Abstract
Purpose To elucidate possible independent associations of
psychological resources with inflammatorymarkers, all linked
with coronary heart disease (CHD).
Method In a middle-aged general population (n=944), psy-
chological resources (coping, self-esteem, and sense of coher-
ence (SOC)), a global measure of quality of life (Cantril’s
self-anchoring ladder, also called “ladder of life”), and psy-
chological risk factors (hopelessness, vital exhaustion, and
depressive symptoms) were used in linear regression models
to evaluate associations with the inflammatory markers inter-
leukin (IL)-6, C-reactive protein (CRP), and matrix metallo-
proteinase (MMP)-9. Adjustments were done for age, sex,
medical conditions, and cardiovascular risk factors.
Results After full adjustments, self-esteem was independently
associated with all three biomarkers. Ladder of life was asso-
ciated with IL-6 and log-CRP; coping, vital exhaustion, and
depressive symptoms with IL-6; and SOC with MMP-9
(p<0.05 for all associations).
Conclusion Numerous significant associations of psycholog-
ical resources and risk factors with IL-6, CRP, and MMP-9
were found in a community-based sample. The associations of
psychological resources were mostly independent, while the
psychological risk factors seemed preferentially dependent on
lifestyle factors as smoking, physical activity, and body mass
index (BMI). This suggests that the psychological resources’
(in particular self-esteem) protective effects on CHD are
linked to inflammatory markers.
Keywords Inflammation . Biomarker . Positive psychology,
self-anchoring ladder . Psychoneuroimmunology .
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Introduction
There is abundant evidence that psychological distress is in-
dependently associated with risk for somatic disease and mor-
tality. More specifically, perceived stress [1, 2], anxiety [2],
depressiveness [2–5], vital exhaustion [6], and hopelessness
[7] have been prospectively associated with incidence and/or
mortality of coronary heart disease (CHD). Recently, a discus-
sion on positive psychology has emerged, raising the question
whether there are shared or unique contributions to health
outcomes when comparing psychological risk factors to psy-
chological resources. As for CHD, there are so far only a few
prospective analyses on the protective effect of psychological
resources. It has been shown that mastery (coping) [8], sense
of coherence (SOC) [8], optimism [9], emotional vitality [10],
and perceived life enjoyment [11] are associated with a lower
incidence of CHD.
Recently, we confirmed the findings on mastery and SOC
and added the knowledge that also self-esteem was indepen-
dently associated with lower risk of first-time CHD events, in
an 8-year follow-up of a middle-aged community-based pop-
ulation [12]. In particular, it was concluded that self-esteem
seems to be of high relevance, as its cardioprotective effect
remained after adjustment for depression or hopelessness [12].
This raises the question through which pathways psychologi-
cal factors exert their effects of CHD.
As CHD is regarded as an inflammatory disease and in-
flammatory markers such as C-reactive protein (CRP) and
interleukin (IL)-6 are well known predictors of incident
CHD [13–15], it has been postulated that there is an associa-
tion between inflammatory markers and psychological fac-
tors. In the rapidly growing field of psychoneuroimmunology
[16, 17], associations between psychological risk factors and
inflammatory biomarkers have been frequently studied, with
IL-6 and CRP as the most studied biomarkers. Associations
have been reported between IL-6 or CRP and depression
[18–20], hopelessness [21], vital exhaustion [20, 21], negative
affect, and psychological distress [22]. In addition, we have
previously shown that psychological risk factors are associat-
ed with matrix metalloproteinase (MMP)-9 [23], a
collagen-degrading enzyme that is up-regulated in inflamma-
tion and involved in the development of atherosclerotic
plaques [24]. Like CRP and IL-6, MMP-9 has been shown
to predict new CHD events [25].
Importantly, in contrast to risk factors, there are few reports
of associations of psychological resources with inflammatory
markers in normal population samples [26]. A potential asso-
ciation has been suggested, but findings from large-scale
population-based studies are few and mixed [26]. Therefore,
more studies on the relation between inflammation and psy-
chological resources are warranted. Such studies could eluci-
date whether the association between psychological resources
and inflammatory markers are confounded by other
cardiovascular risk factors or if the association is independent.
We have previously reported independent associations of the
psychological resources coping, self-esteem, and SOC, with
IL-6 in a selected sample from a normal population [21], and
also of coping, self-esteem, and SOC with MMP-9 in a subset
of the present sample [23].
The aim of this study was to investigate whether psycho-
logical resources with reported CHD protective effects are
associated, either independently or not from cardiovascular
risk factors, with three functionally different inflammatory
markers related to CHD incidents, namely, IL-6, CRP, and
MMP-9. Our hypothesis was that psychological resources
would be associated with inflammatory markers, independent
of cardiovascular risk factors.
Methods
Study Population and Procedures
The sample constitutes the baseline of the prospective Life
Conditions, Stress, and Health (LSH) study [27], with the
main aim to investigate to what extent psychosocial factors
and biological markers for stress and inflammation can ex-
plain differences of incident myocardial infarction in relation
to socioeconomic status.
Data collection was performed in collaboration with ten
primary healthcare centers (PHCs) in the county of
Östergötland in the southeast of Sweden. All citizens in the
age range of 45 to 69 years living in any of the catchment areas
of the ten PHCs were eligible for invitation.
The participants were invited consecutively to reach a
study population size of n=1000, evenly distributed in terms
of age and sex (age range of 45–69 years). An invitation letter
was sent by post, and signing and returning the reply form
constituted the provision of informed consent. The response
rate was 62 %. The data collection was conducted from
October 2003 to June 2004 and constituted a brief health ex-
amination at a PHC, collection of morning blood samples in a
fasting state, and self-reported measures evaluated by ques-
tionnaire. Subjects were instructed not to attend when they
were experiencing any acute infections. Exclusion criteria
were self-reported severe diseases, such as terminal cancer,
severe dementia, and psychiatric disorders. The study sample
was representative of the population in terms of educational
attainment, immigrant status, and rate of employment. The
study was approved by the Regional Ethics Review Board
of Linköping University, Linköping, Sweden (02–0324).
Medical Conditions and Other Cardiovascular Risk Factors
Medical conditions related to inflammation were covered a
priori with a checklist regarding whether the participants had
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ever been diagnosed by a doctor with any of the following
conditions: acute coronary syndrome (ACS), angina pectoris,
stroke, chronic obstructive pulmonary disease (COPD), can-
cer, asthma, allergy, and peptic ulcer. Furthermore, diagnoses
of rheumatic disease, fibromyalgia, and herniated disks were
captured using the question “Have you ever had any other
chronic or long-term disease diagnosed by a medical doctor?
(Yes/no/do not know. If yes, please specify).”
Smoking habits were based on self-reports of being a reg-
ular smoker (yes, at least one cigarette a day/no) or not. Those
who had quit smoking within the last 5 years due to illness
were also included in the smoker category. Questions about
fruit and vegetables and alcohol consumption were from the
validated Food Frequency Questionnaire adopted from the
Swedish Mammography Cohort [28]. Physical activity was
measured using questions about daily physical activity and
planned physical exercise [29]. The two middle categories of
the original four were merged into one middle category to
minimize ordinal misclassification.
The individuals’ weight and height were obtained during
visits to the PHC and used for calculating body mass index
(BMI). Systolic and diastolic blood pressures (SBP and DBP)
were measured three times in a sitting position after 5 min of
rest (Omron M5-1 digital). The mean of the second and third
measurements was used. Blood lipids and glucose were ana-
lyzed directly after sample collection (ADVIA 1650 and
Hemocue glucose system).
Psychological Assessments
The LSH study uses validated psychometric instruments that
have been previously used in population based studies and
that have a plausible predictive value for new coronary events.
Three measures of psychological resources were used in
this specific study, namely, coping, self-esteem, and SOC.
These were shown in an 8-year follow-up of the LSH study
to predict new coronary events, independently of cardiovas-
cular risk factors [12]. Coping captures feelings of confidence
and self-reliance with an experience that life to some extent is
manageable and was measured with Pearlin and Schooler’s
seven-item questionnaire [30]. Self-esteem was measured by
the Pearlin’s ten-item adaptation of Rosenberg’s self-esteem
[31], which contains both a global dimension of basic self-
worth and a comparison with other people’s competences
[30]. SOC was measured by the 13-item version of the scale
by Antonovsky which assesses to what extent life is regarded
as manageable, comprehensive, and meaningful [32].
In addition, Cantril’s measure of global quality of life (lad-
der of life) was used as a measure of life satisfaction and
positive outlook [33].
Three measures of psychological risk factors were used,
namely, hopelessness, depressive symptoms, and vital ex-
haustion. Hopelessness was measured by the Everson’s 2-
item scale [7] and depressive symptoms by the 20-item
questionnaire from the Center for Epidemiological Studies
Depression Scale (CES-D) [34]. Vital exhaustion was mea-
sured by the 19-item questionnaire that captures feelings of
physical and mental fatigue [35].
Biochemical Analyses
Levels of IL-6 were measured in EDTA plasma using
Ultrasensitive Bead Kit Technology (Invitrogen Co.,
Carlsbad, CA, USA) on a Luminex® 100™ System (Austin,
TX, USA). The lower detection limit was set at 1.68 pg/mL
for IL-6. The inter-assay coefficient of variation (CV%) was
7.0 %. The detection rate was 40 %. Due to the low detection
rate, IL-6 was also analyzed in a randomly selected subset of
the study population (n=380) by a highly sensitive ELISA
immunoassay (Quantikine HS, R&D Systems Europe Ltd.,
Abingdon, UK), with a detection rate of 100 % (detection
limit 0.04 pg/mL and CV% 7.8 %).
CRP was measured in plasma by a highly sensitive
latex-enhanced turbidimetric immunoassay (Roche
Diagnostics GmbH, Vienna, Austria) with a lower detection
limit of 0.03 mg/L (CV% 1.6 %) and with a detection rate of
100 %.
Concentrations ofMMP-9weremeasured in EDTA plasma
[36] using human Biotrak ELISA systems (Amersham
Biosciences, Uppsala, Sweden). The assay for MMP-9 mea-
sures total quantification, that is, biologically free MMP-9,
along with inactive pro-MMP-9 and the complex
pro-MMP-9/tissue inhibitor of metalloproteinases-1. The low-
er detection limit was 0.6 ng/mL (CV% 6.8 %) and the detec-
tion rate was 100 %. Aliquots of plasma (0.5 mL) were stored
at −70 °C for approximately 18 months before laboratory
analysis of MMP-9 in a subset of the sample population
(n=400) and approximately 40 months before analyses of
the remaining MMP-9 samples and the other biomarkers.
Analyses by ELISAwere run in duplicates.
Statistical Analysis
Circulating levels of the biomarkers IL-6, CRP, and MMP-9
were set as the main outcomes. In order to avoid an influence
of acute infection, all subjects with CRP levels higher than the
clinically accepted cutoff of 10 mg/L were excluded (n=32,
mean 20.6 mg/L). Further, all IL-6 levels over >20 pg/mL
were excluded (n=17, mean 73 pg/mL), based on a cutoff
of 3 SD higher than mean after exclusion of extreme outliers
(about hundredfold the mean, >200 pg/mL). Likewise, four
values of MMP-9 were more than 3 SD higher than any of the
others (cutoff >200 mg/mL and mean 262 ng/mL) and were
excluded prior to analyses.
Chi-squared tests and t tests were performed to test for group
differences. Pearson’s product–moment correlations and linear
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regressions were used to test associations between variables. A
set of linear regression models were run to test the associations
between psychological instruments and inflammatory markers.
There were three steps as follows: (a) adjustments solely for age
and sex; (b) adjustments for age, sex, and medical conditions
related to inflammation (ACS, angina pectoris, stroke, COPD,
rheumatic disease, asthma, cancer, fibromyalgia, peptic ulcer,
and herniated disks); and (c) adjustments for the age, sex, and
medical conditions related to inflammation plus cardiovascular
risk factors, smoking, alcohol intake, fruit and vegetable in-
takes, physical activity, BMI, SBP, blood glucose, and HDL.
Further, psychosocial resources were adjusted for psychosocial
risk factors and vice versa in post hoc analyses. In these anal-
yses, depressive symptoms were included in two ways, as a
dichotomous variable using a CES-D cutoff score of 16 or
higher (since this has been suggested to discriminate clinically
significant depressive symptoms in a general population [34])
or as a continuous score of CES-D.
Owing to a skewness in the distribution of the biomarkers, all
of the above models were run with both continuous and
log-transformed outcomes.
A two-sided probability value of p≤0.05 was considered as
statistically significant. Analyses were performed using STATA
statistical software, release 11.0 (Stata Corporation, College
Station, TX, USA), and IBM SPSS for Windows statistical
software, release 21 (IBM Corporation, Armonk, NY, USA).
Results
Data were available for 944 participants after exclusion of ab-
normal levels of inflammatory markers. Descriptive character-
istics are given in Table 1. Women scored significantly lower
than men on coping (p=0.019) and self-esteem (p=0.002) but
significantly higher on hopelessness, depression, and vital ex-
haustion (p for all <0.001). In addition, women had significant-
ly higher CRP values (p=0.007) but lower MMP-9 values
(p<0.001), while the levels of IL-6 did not differ significantly
between women and men (data not shown).
Table 2 shows the associations of inflammatory biomarkers
with cardiovascular risk factors. IL-6 values fromELISA (n=377)
were chosen instead of IL-6 for Luminex (n=944) as the for-
mer had a detection rate of 100 %. Abundant significant asso-
ciations were shown between cardiovascular risk factors and
levels of IL-6, CRP, and MMP-9.
Table 3 shows the associations of cardiovascular risk factors
with psychological factors. Regarding self-esteem, there were
non-significant associations to all investigated factors except
sex, fruit intake, BMI, and medical conditions (p<0.01). BMI
was associated with all other psychological factors (p<0.05);
the associations were negative for resources and positive for
risk factors. Smokingwas associated with all psychological risk
factors and one psychological resource, the ladder of life
(p<0.05). Physical activity showed a similar pattern of
associations to all psychological factors (p< 0.05), except
coping and self-esteem. Fruit intake was associated with
all resources except the ladder of life and one risk factor,
hopelessness (p < 0.05). Alcohol intake was associated
with one resource, SOC, and one risk factor, vital exhaus-
tion (p< 0.05). Neither blood glucose nor blood pressure
or blood lipids were associated with any of the psycho-
logical factors, with the exception of the association of
HDL with hopelessness (p< 0.05).
All psychological measures are significantly correlated
with each other. The lowest correlation is found between
hopelessness and ladder of life (r=−0.36). The highest corre-
lation is found between CES-D and vital exhaustion (r=0.76).
Table 4 shows the results from a set of regression
models on the inflammatory biomarkers IL-6 (using
ELISA analyses), log-CRP and MMP-9 with psychologi-
cal measures as independent variables. All analyses were
carried out on both continuous and log-transformed data
of the biomarkers. The log transformation did not alter the
associations for the biomarkers, except for CRP.
Continuous CRP was significantly associated with one
of the psychological measures (ladder of life) but to six
measures when log-transformed CRP was used. The anal-
yses on IL-6 by the Luminex method corroborate the find-
ings on IL-6 using ELISA, despite a low detection rate. In
the full regression models, the same significant associa-
tions were noted to psychological measures shown in
Table 4, except for CES-D (p= 0.138). However, all re-
gression coefficients were lower when using Luminex in-
stead of ELISA measures (ranging from −0.19 to 0.22 pg/
mL per SD increment).
The regression coefficients are relatively small, but the
associations are found in expected directions. After ad-
justment for age and sex, significant associations were
found for all psychological factors with IL-6, for all but
coping with log-CRP and for all but three (coping, hope-
lessness, and vital exhaustion) for MMP-9. Controlling
for presence of somatic disease in the second step of the
regression models displayed small effects with loss of
significant relationships between the ladder of life and
MMP and vital exhaustion for CRP. After full adjustments
also for medical conditions and cardiovascular risk fac-
tors, self-esteem was independently associated with all
three biomarkers (p< 0.05). Ladder of life was associated
with IL-6 and log-CRP (p< 0.05); coping, vital exhaus-
tion, and depressive symptoms with IL-6 (p< 0.05); and
SOC with MMP-9 (p< 0.05).
In post hoc analyses, we used the model “c” presented in
Table 4 but adjusted psychological resources for psychologi-
cal risk factors and vice versa. Overall, hopelessness, depres-
sive symptoms (either as continuous or dichotomous vari-
able), and vital exhaustion had low effect on the association
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between psychosocial resources and inflammatory markers.
There were only two specific models in which a psychological
risk factor was significantly associated with the inflammatory
marker at hand when entered together with a psychological
resource. Those associations were found between IL-6 and
depressive symptoms (dichotomous) entered either with
coping or with ladder of life (p for CES-D = 0.042 and
0.047, respectively).
For resources and ladder of life, on the other hand, most
associations with inflammatorymarkers remained after adjust-
ment for psychosocial risk factors. Coping remained associat-
ed with IL-6 regardless of adjustment for hopelessness, vital
Table 1 Descriptive
characteristics of the study
population
– Total number Number (%) Mean (SD)
Sex 944 – –
Women – 473 (50) –
Age 944 – –
45–49 years – 184 (19) –
50–54 years – 192 (20) –
55–60 years – 195 (21) –
60–65 years – 188 (20) –
65–69 years – 185 (20) –
Educational attainment 927 – –
9 years or less – 329 (35) –
10–11 years – 276 (30) –
12–13 years – 128 (14) –
College/university – 194 (21) –
Lifestyle factors
Smoking (yes) 880 90 (20) –
Alcohol consumption 923 – –
Low consumption – 744 (80) –
Elevated consumption – 89 (10) –
High consumption – 90 (10) –
Physical activity 876 – –
Regularly active – 167 (19) –
Occasionally/seldom active – 670 (76) –
Inactive – 39 (4) –
Fruit and vegetable intakes 926 – –
Low intake – 127 (14) –
Medium intake – 661 (71) –
High intake – 138 (15) –
Physical factors
BMI (kg/m2) 935 – 26.8 (4.2)
SBP (mm Hg) 931 – 133 (20.2)
DBP (mm Hg) 931 – 84 (11.6)
LDL cholesterol (mmol/L) 921 – 3.4 (0.88)
HDL cholesterol (mmol/L) 937 – 1.5 (0.36)
Plasma glucose (mmol/L) 932 – 5.4 (1.2)
Inflammatory medical conditionsa 944 184 (19) –
Biomarkers
IL-6 (pg/mL) Luminex 944 – 2.0 (2.7)
IL-6 (pg/mL) ELISA 377 – 2.2 (1.7)
CRP (mg/L) 928 – 1.7 (2.0)
MMP-9 (ng/mL) 903 – 35.2 (23.1)
a Defined a priori as participants diagnosed with ACS, angina pectoris, stroke, COPD, cancer, asthma, allergy,
peptic ulcer, rheumatic disease, fibromyalgia, and/or herniated disk
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exhaustion, or depressive symptoms (continuous or dichoto-
mous). Self-esteem remained significantly associated with
IL-6, CRP, and MMP-9 also after adjustment for hopeless-
ness, vital exhaustion, or depression using dichotomy scale
and with marginal significance for IL-6 (p=0.06) and CRP
(p=0.061) after control for depression using continuous scale.
Sense of coherence remained significantly associated with
MMP-9 after adjustment for vital exhaustion or CES-D
(dichotomous) but marginally when adjusted for hopelessness
(p=0.052) and CES-D (continuous, p=0.100).
Ladder of life remained significantly associated with IL-6
regardless of adjustment for any of the psychosocial risk fac-
tors but was not with associated with CRP after adjustment for
any of those.
Discussion
This study investigated associations between psychological and
inflammatory predictors of CHD in a community-based sample.
Significant associations of psychological resources and risk fac-
tors with IL-6, CRP, and MMP-9 were shown. The associations
are consistently found in expected directions, with psychological
resources associated with lower levels of inflammatory markers
and psychological risk factors associated with higher levels of
inflammatory markers. Interestingly, psychological resources
associated with other cardiovascular risk factors to a lower de-
gree than is the case for psychological risk factors. As a conse-
quence, adjustments for cardiovascular risk factors have a higher
impact on the association between psychological risk factors and
inflammatory markers.
One important notion is that several of the significant as-
sociations between psychological resources remain after ad-
justment for psychological risk factors. Thus, the measures
may appear similar but do capture different psychological
constructs and are therefore not redundant measures.
Of note, self-esteem displayed independent associations to
all the three inflammatory markers. This is interesting in view
of our previous findings, highlighting self-esteem as an indepen-
dent predictor of CHD events, also after control for depression
or hopelessness [12]. Hence, self-esteem may be worth con-
sidering in the search of future health predictors and for plan-
ning of preventive actions against CHD events. The
self-esteem scale aims to capture the positivity of one’s attitudes
toward oneself and self-worth [30].
The findings of independent significant associations of
ladder of life with IL-6 and CRP are in line with prior
studies on positive affect and life satisfaction in women
Table 2 Cardiovascular risk
factors in relation to inflammatory
biomarkers
IL-6 (n= 344) CRP (n= 928) MMP-9 (n= 903)
β p β p β p
Sex (women vs. men) −0.36 0.040 0.35 0.002 −7.38 <0.001
Age (5-year categories) 0.28 <0.001 0.14 0.007 −0.56 0.294
Lifestyle factors
Smoking (yes/no) 0.50 0.031 0.55 0.002 12.87 <0.001
Alcohol intake (three categories) 0.32 0.023 −0.13 0.059 1.82 0.025
Fruit/vegetable intake (three categories) 0.10 0.544 −0.01 0.935 −3.90 0.006
Physical activity (three categories) −0.43 0.029 −0.54 <0.001 −8.24 <0.001
Physical factors
BMI (three categories) 0.64 <0.001 0.89 <0.001 3.67 <0.001
SBP (SD 20 mm Hg) 0.25 0.005 0.25 <0.001 2.70 0.001
DBP (SD 11 mm Hg) 0.21 0.010 0.27 <0.001 2.19 0.004
LDL cholesterol (SD 0.87 mmol/L) −0.17 0.070 −0.03 0.615 1.0 0.185
HDL cholesterol (SD 0.36 mmol/L) −0.37 <0.001 −0.46 <0.001 −3.4 <0.001
Glucose (SD 1.2 mmol/L) 0.25 0.006 0.27 <0.001 0.56 0.461
Inflammatory medical conditiona 0.53 0.022 0.36 0.029 4.70 0.013
Biomarkers
IL-6 (pg/mL) – n.a. 0.89 <0.001 4.95 0.001
CRP (mg/L) 0.61 <0.001 – n.a. 7.74 <0.001
MMP-9 (ng/mL) 0.51 <0.001 0.51 <0.001 – n.a.
Regressions adjusted for age and sex. Βeta coefficient expressed as an increase of circulating levels per dichot-
omy, category, or SD increment
a Defined a priori as participants diagnosed with ACS, angina pectoris, stroke, COPD, cancer, asthma, allergy,
peptic ulcer, rheumatic disease, fibromyalgia, and herniated disks at baseline
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[37] as well as on optimism in older men [38]. To our
knowledge, this instrument has not been used before in
psychoimmunological investigations. It is suggested as a
relevant measure when scrutinizing the interplay between
psychological dimensions and immunologic markers.
The association between MMP-9 and SOC supports
earlier published results from a subset of this study [23].
MMP-9 is a rather new biomarker in the field of psycho-
neuroimmunology, which makes this finding interesting
but hard to evaluate until further research has accumulated
on this topic.
In agreement with several earlier studies [18–21], IL-6 was
the biological marker most frequently associated with psycho-
logical factors, thus confirming that IL-6 is a robust marker in
the field of psychoneuroimmunology. Contradicting the
Multi-Ethnic Study of Atherosclerosis (MESA) and the
Whitehall II studies [37, 39], significant associations of IL-6
mostly remained after adjustments for cardiovascular risk
factors, even in a separate post hoc analysis simulating the
MESA study model (not shown) [39].
As compared with IL-6, a larger proportion of associations
to CRP and MMP-9 became non-significant after adjustments
for other cardiovascular risk factors. This suggests that the re-
lations of psychological measures to MMP-9 and CRP depend
on cardiovascular risk factors to a higher extent than is the case
for IL-6 thereby suggesting that biomarkers related to inflam-
mation should not be used interchangeably but rather be treated
as markers of different immunological functions.
As for psychological risk factors, their influences on in-
flammatory markers seem to be associated to a larger degree
with cardiovascular risk factors. Of note, neither psychologi-
cal risk factors nor resources showed significant associations
with levels of glucose, blood pressure, or blood lipids.
Therefore, it is plausible that the associations of hopelessness
with IL-6 and CRP and of depression with CRP and MMP-9,
all of which vanished after adjustment for physical and
Table 4 Psychological factors in relation to IL-6, CRP, and MMP-9 after adjustments
IL-6 (n = 288 to 329) Model a Model b Model c
β p β p β p
Coping (SD 3.4) −0.37 <0.001 −0.35 <0.001 −0.29 0.003
Self-esteem (SD 4.8) −0.34 0.001 −0.32 0.001 −0.28 0.004
SOC (SD 10.4) −0.23 0.024 −0.21 0.039 −0.15 0.136
Ladder of life (SD 1.7) −0.50 <0.001 −0.49 <0.001 −0.38 <0.001
Hopelessness (SD 2.0) 0.27 0.014 0.24 0.027 0.19 0.071
Depression CES-D (SD 7.8) 0.41 <0.001 0.39 <0.001 0.27 0.010
Vital exhaustion (SD 7.6) 0.39 <0.001 0.36 0.001 0.26 0.017
Log-CRP (n= 703–803)
Coping (SD 3.4) −0.08 0.078 −0.08 0.098 −0.05 0.291
Self-esteem (SD 4.8) −0.11 0.021 −0.11 0.016 −0.09 0.037
SOC (SD 10.4) −0.09 0.047 −0.10 0.043 −0.06 0.194
Ladder of life (SD 1.7) −0.12 0.008 −0.15 0.004 −0.09 0.036
Hopelessness (SD 2.0) 0.12 0.014 0.10 0.042 0.04 0.434
Depression CES-D (SD 7.8) 0.12 0.012 0.10 0.046 0.06 0.179
Vital exhaustion (SD 7.6) 0.11 0.021 0.09 0.069 0.04 0.444
MMP-9 (n= 688–784)
Coping (SD 3.4) −1.32 0.094 −1.45 0.085 −0.92 0.253
Self-esteem (SD 4.8) −1.74 0.030 −2.05 0.016 −1.67 0.040
SOC (SD 10.4) −2.17 0.006 −2.38 0.005 −1.84 0.026
Ladder of life (SD 1.7) −1.67 0.038 −1.54 0.075 −1.05 0.204
Hopelessness (SD 2.0) 1.02 0.195 0.94 0.280 0.18 0.833
Depression CES-D (SD 7.8) 1.84 0.022 1.91 0.026 1.10 0.185
Vital exhaustion (SD 7.6) 1.29 0.107 1.18 0.172 0.52 0.538
Βeta coefficient expressed as increase of circulating levels of IL-6 (pg/mL), CRP (mg/L), andMMP-9 (ng/mL) per SD increment. Coefficient for CRP is
log-transformed in regression and then back-transformed in table
Model a adjusted for age and sex; model b adjusted for age, sex, and medical conditions (angina pectoris, ACS, stroke, COPD, rheumatic disease,
asthma, cancer, fibromyalgia, peptic ulcer, and herniated disks); andmodel c adjusted for age, sex, andmedical conditions (smoking, alcohol intake, fruit
and vegetable intakes, physical activity, body mass index, blood pressure, blood lipids, and blood glucose)
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lifestyle factors, are mainly reliant on lifestyle factors. The
lifestyle factors, smoking and physical activity and subse-
quently BMI, may be of particular importance for these asso-
ciations as linked with all the involved parameters.
Interestingly, the presence of medical conditions only mar-
ginally influenced the associations between inflammatory
markers and psychological factors in line with previous re-
search [40]. Only the associations of vital exhaustion with
CRP as well as of the ladder of life with MMP-9 seem to be
confounded by inflammatory medical conditions. This seems
reasonable as vital exhaustion may be a part of somatic disor-
der which in turn also may moderate optimism, approximated
by the ladder of life.
Limitations and Strengths
The high proportion of measured samples with cytokine levels
under the detection level is of concern. However, it was possible
to validate the findings on IL-6 levels by using a high-sensitivity
ELISA approach on a subset of the study population. The two
different laboratory techniques generated consistent results in
regression models, although the ELISAmethod provided slight-
ly larger effect sizes. This was probably due to the ability of the
ELISA method to quantify also lower levels of IL-6.
The choice to have inflammatory markers as a dependent
outcome may be a matter of some controversies as the direc-
tion could be the other way around, namely, that the cytokines
contribute to psychological disposition [18, 41]. As our pri-
mary interest was to study through which pathways psycho-
logical factors exert their effects on CHD, we chose inflam-
matory markers as a dependent outcome in this study.
The number of analyses performed may increase the risk of
alpha errors.We have chosen not to adjust for mass significance
(for example, Bonferroni correction) as it might over-adjust
significance level due to high correlations between the psycho-
logical measures. Due to the collinearity, the risk of beta-errors
is high too, in particular, in the regression models where both
resources and risk factors were entered at the same time. Thus,
these regressions should be interpreted with caution.
There are a number of strengths in this study of a large-scale
well-characterized community-based sample. One particular
benefit is the broad range of psychological constructs of both
resources and risk factors. Despite the relatively small number
of participants in comparison to other large-scale community-
based studies, we were able to demonstrate significant findings
in expected directions for several psychological measures, even
after broad adjustment for confounders.
Conclusion
Numerous significant associations of psychological resources
and risk factors with IL-6, CRP, and MMP-9 were found in a
community-based sample. The associations of psychological
resources were mostly independent, while the psychological
risk factors seemed preferentially dependent on lifestyle fac-
tors as smoking, physical activity, and BMI. This suggests that
the psychological resources’ (in particular self-esteem) protec-
tive effects on CHD are linked to inflammatory markers.
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